- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
The marketing authorisation for BTVPUR AlSap 8 has been withdrawn at the request of the marketing-authorisation holder.
BTVPUR Alsap 8 : EPAR - Summary for the public
English (EN) (216.22 KB - PDF)
български (BG) (276.19 KB - PDF)
español (ES) (214.85 KB - PDF)
čeština (CS) (282.09 KB - PDF)
dansk (DA) (238.31 KB - PDF)
Deutsch (DE) (217.39 KB - PDF)
eesti keel (ET) (214.24 KB - PDF)
ελληνικά (EL) (304.53 KB - PDF)
français (FR) (239.03 KB - PDF)
italiano (IT) (215.73 KB - PDF)
latviešu valoda (LV) (94.58 KB - PDF)
lietuvių kalba (LT) (119.27 KB - PDF)
magyar (HU) (257.98 KB - PDF)
Malti (MT) (122.68 KB - PDF)
Nederlands (NL) (71.87 KB - PDF)
polski (PL) (100.02 KB - PDF)
português (PT) (71.88 KB - PDF)
română (RO) (118.17 KB - PDF)
slovenčina (SK) (120.6 KB - PDF)
slovenščina (SL) (110.34 KB - PDF)
Suomi (FI) (216.27 KB - PDF)
svenska (SV) (71.75 KB - PDF)
Product information
BTVPUR Alsap 8 : EPAR - Product Information
English (EN) (409.23 KB - PDF)
български (BG) (743.97 KB - PDF)
español (ES) (471.21 KB - PDF)
čeština (CS) (625.92 KB - PDF)
dansk (DA) (404.57 KB - PDF)
Deutsch (DE) (481.49 KB - PDF)
eesti keel (ET) (481.1 KB - PDF)
ελληνικά (EL) (760 KB - PDF)
français (FR) (417.92 KB - PDF)
hrvatski (HR) (521.62 KB - PDF)
íslenska (IS) (401.48 KB - PDF)
italiano (IT) (414.09 KB - PDF)
latviešu valoda (LV) (649.44 KB - PDF)
lietuvių kalba (LT) (540.05 KB - PDF)
magyar (HU) (652.27 KB - PDF)
Malti (MT) (653.21 KB - PDF)
Nederlands (NL) (474.89 KB - PDF)
norsk (NO) (402.13 KB - PDF)
polski (PL) (661.05 KB - PDF)
português (PT) (476.05 KB - PDF)
română (RO) (543.38 KB - PDF)
slovenčina (SK) (663.03 KB - PDF)
slovenščina (SL) (624.08 KB - PDF)
Suomi (FI) (407.04 KB - PDF)
svenska (SV) (406.34 KB - PDF)
BTVPUR Alsap 8 : EPAR - All Authorised presentations
English (EN) (168.89 KB - PDF)
български (BG) (241.84 KB - PDF)
español (ES) (177.73 KB - PDF)
čeština (CS) (211.31 KB - PDF)
dansk (DA) (164.97 KB - PDF)
Deutsch (DE) (173.27 KB - PDF)
eesti keel (ET) (172.66 KB - PDF)
ελληνικά (EL) (237.8 KB - PDF)
français (FR) (165.01 KB - PDF)
íslenska (IS) (166.62 KB - PDF)
italiano (IT) (166.47 KB - PDF)
latviešu valoda (LV) (214.89 KB - PDF)
lietuvių kalba (LT) (212.85 KB - PDF)
magyar (HU) (204.67 KB - PDF)
Malti (MT) (225.73 KB - PDF)
Nederlands (NL) (172.82 KB - PDF)
norsk (NO) (164.38 KB - PDF)
polski (PL) (236.78 KB - PDF)
português (PT) (176.81 KB - PDF)
română (RO) (210.41 KB - PDF)
slovenčina (SK) (210.94 KB - PDF)
slovenščina (SL) (209.82 KB - PDF)
Suomi (FI) (173.21 KB - PDF)
svenska (SV) (165.48 KB - PDF)
Product details
- Name of medicine
- BTVPUR Alsap 8
- Active substance
- bluetongue virus serotype 8 antigen
- International non-proprietary name (INN) or common name
- adjuvanted bluetongue virus vaccine
- Species
- Sheep
- Cattle
- Anatomical therapeutic chemical veterinary (ATCvet) code
- QI02AA08
Pharmacotherapeutic group
- Immunologicals for Ovidae
- Immunologicals for Bovidae
Therapeutic indication
Active immunisation of sheep and cattle to prevent viraemia* and to reduce clinical signs caused by bluetongue virus serotype 8.
*(below the level of detection by the validated RT-PCR method at 3.14log10 RNA copies/ml, indicating no infectious virus transmission).
Onset of immunity has been demonstrated 3 weeks after the primary vaccination course.
The duration of immunity for cattle and sheep is 1 year after the primary vaccination course.
The duration of immunity is not yet fully established in cattle or sheep, although interim results of ongoing studies demonstrate that the duration is at least 6 months after the primary vaccination course in sheep.
Authorisation details
- EMA product number
- EMEA/V/C/000146
- Marketing authorisation holder
- Merial
29 Avenue Tony Garnier
69007 Lyon
France - Marketing authorisation issued
- 17/03/2009
- Revision
- 5
Assessment history
BTVPUR Alsap 8 : EPAR - Procedural steps taken and scientific information after authorisation
English (EN) (213.44 KB - PDF)
BTVPUR Alsap 8-V-C-146-S-08 : EPAR - Assessment Report - Variation
English (EN) (308.64 KB - PDF)
BTVPUR Alsap 8 : EPAR - Scientific Discussion
English (EN) (619.07 KB - PDF)
BTVPUR Alsap 8 : EPAR - Procedural steps taken before authorisation
English (EN) (193.91 KB - PDF)
Committee for medicinal products for veterinary use summary of opinion: BTVPUR Alsap 8: International Non-proprietary Names (INN): inactivated bluetongue virus Serotype 8
English (EN) (168.92 KB - PDF)